Abstract
Annual Review of Immunology
Vol. 17:
657-700
(Volume publication date April 1999)
(doi:10.1146/annurev.immunol.17.1.657)
CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and Disease Edward A. Berger1, Philip M. Murphy2 and Joshua M. Farber31Laboratory of Viral Diseases, 2Laboratory of Host Defenses and 3Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892; e-mail: Edward_Berger@nih.gov ▪ Abstract In addition to CD4, the human immunodeficiency virus (HIV) requires a coreceptor for entry into target cells. The chemokine receptors CXCR4 and CCR5, members of the G protein-coupled receptor superfamily, have been identified as the principal coreceptors for T cell line-tropic and macrophage-tropic HIV-1 isolates, respectively. The updated coreceptor repertoire includes numerous members, mostly chemokine receptors and related orphans. These discoveries provide a new framework for understanding critical features of the basic biology of HIV-1, including the selective tropism of individual viral variants for different CD4+ target cells and the membrane fusion mechanism governing virus entry. The coreceptors also provide molecular perspectives on central puzzles of HIV-1 disease, including the selective transmission of macrophage-tropic variants, the appearance of T cell line-tropic variants in many infected persons during progression to AIDS, and differing susceptibilities of individuals to infection and disease progression. Genetic findings have yielded major insights into the in vivo roles of individual coreceptors and their ligands; of particular importance is the discovery of an inactivating mutation in the CCR5 gene which, in homozygous form, confers strong resistance to HIV-1 infection. Beyond providing new perspectives on fundamental aspects of HIV-1 transmission and pathogenesis, the coreceptors suggest new avenues for developing novel therapeutic and preventative strategies to combat the AIDS epidemic. Most recent citing papers (via CrossRef)Translational Mini-Review Series on Vaccines for HIV: Harnessing innate immunity for HIV vaccine development Clinical & Experimental Immunology 157(2):174-180 (2009) For whom the bell tolls? DING proteins in health and disease Cellular and Molecular Life Sciences 66(14):2205-2218 (2009) High frequency of X4/DM-tropic viruses in PBMC samples from patients with primary HIV-1 subtype-B infection in 1996-2007: the French ANRS CO06 PRIMO Cohort Study Journal of Antimicrobial Chemotherapy 64(1):135-141 (2009) Thalidomide: an emerging drug in oral mucosal lesions Clinical Journal of Gastroenterology 2(3):149-155 (2009) An Indel in Transmembrane Helix 2 Helps to Trace the Molecular Evolution of Class A G-Protein-Coupled Receptors Journal of Molecular Evolution 68(5):475-489 (2009)
|
|
|
Users who read this review also read:
| Ralph Pantophlet, Dennis R. Burton Annual Review of Immunology. Volume 24, Page 739-769, Apr 2006 Abstract
| Full Text
| PDF (720 KB)
|
Add to Favorites
| Related | |
| Michael Dougan, Glenn Dranoff Annual Review of Immunology. Volume 27, Page 83-117, Apr 2009 Abstract
| Full Text
| PDF (427 KB)
|
Add to Favorites
| Related | |
| Thomas R. Malek Annual Review of Immunology. Volume 26, Page 453-479, Apr 2008 Abstract
| Full Text
| PDF (223 KB)
|
Add to Favorites
| Related | |
| Federica Sallusto , Charles R. Mackay , Antonio Lanzavecchia Annual Review of Immunology. Volume 18, Page 593-620, Apr 2000 Abstract
| Full Text
| PDF (285 KB)
|
Add to Favorites
| Related | |
|
|